Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Placebo on Bleeding Time in Healthy Subjects
NCT02183155Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2000
- Primary completion
- Sep 2000
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of meloxicam in osteoarthritis (OA), rheumatoid arthritis (RA), sponsored by Boehringer Ingelheim. Started May 2000; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02183155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183155.